Janowsky A - Search Results

1

Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.

Eshleman AJ, Forster MJ, Wolfrum KM, Johnson RA, Janowsky A, Gatch MB. Eshleman AJ, et al. Among authors: janowsky a. Psychopharmacology (Berl). 2014 Mar;231(5):875-88. doi: 10.1007/s00213-013-3303-6. Epub 2013 Oct 19. Psychopharmacology (Berl). 2014. PMID: 24142203 Free PMC article.

2

Characterization of a recombinant human dopamine transporter in multiple cell lines.

Eshleman AJ, Neve RL, Janowsky A, Neve KA. Eshleman AJ, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 1995 Jul;274(1):276-83. J Pharmacol Exp Ther. 1995. PMID: 7616409

3

Release of dopamine via the human transporter.

Eshleman AJ, Henningsen RA, Neve KA, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. Mol Pharmacol. 1994 Feb;45(2):312-6. Mol Pharmacol. 1994. PMID: 7906856

4

Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters.

Eshleman AJ, Stewart E, Evenson AK, Mason JN, Blakely RD, Janowsky A, Neve KA. Eshleman AJ, et al. Among authors: janowsky a. J Neurochem. 1997 Oct;69(4):1459-66. doi: 10.1046/j.1471-4159.1997.69041459.x. J Neurochem. 1997. PMID: 9326274 Free article.

5

[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.

Johnson RA, Eshleman AJ, Meyers T, Neve KA, Janowsky A. Johnson RA, et al. Among authors: janowsky a. Synapse. 1998 Sep;30(1):97-106. doi: 10.1002/(SICI)1098-2396(199809)30:1<97::AID-SYN12>3.0.CO;2-M. Synapse. 1998. PMID: 9704886

6

Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.

Eshleman AJ, Carmolli M, Cumbay M, Martens CR, Neve KA, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 1999 May;289(2):877-85. J Pharmacol Exp Ther. 1999. PMID: 10215666

7

Drug interactions with the dopamine transporter in cryopreserved human caudate.

Eshleman AJ, Wolfrum K, Mash DC, Christensen K, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 2001 Feb;296(2):442-9. J Pharmacol Exp Ther. 2001. PMID: 11160629

8

NMDA receptor subunit mRNA and protein expression in ethanol-withdrawal seizure-prone and -resistant mice.

Mason JN, Eshleman AJ, Belknap JK, Crabbe JC, Loftis JM, Macey TA, Janowsky A. Mason JN, et al. Among authors: janowsky a. Alcohol Clin Exp Res. 2001 May;25(5):651-60. Alcohol Clin Exp Res. 2001. PMID: 11371713

9

Mapping genes that regulate density of dopamine transporters and correlated behaviors in recombinant inbred mice.

Janowsky A, Mah C, Johnson RA, Cunningham CL, Phillips TJ, Crabbe JC, Eshleman AJ, Belknap JK. Janowsky A, et al. J Pharmacol Exp Ther. 2001 Aug;298(2):634-43. J Pharmacol Exp Ther. 2001. PMID: 11454925

10

Cocaine treatment- and withdrawal-induced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunit.

Loftis JM, Janowsky A. Loftis JM, et al. Among authors: janowsky a. Psychopharmacology (Berl). 2002 Dec;164(4):349-59. doi: 10.1007/s00213-002-1209-9. Epub 2002 Sep 20. Psychopharmacology (Berl). 2002. PMID: 12457264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters